← Back to Jenburkt Pharmaceuticals Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
JENBURPHPharmaceuticals

Jenburkt Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹955.45
+0.34%
P/E Ratio15.33xIndustry: 31.77x
ROE19.87%Return on equity
ROCE27.18%Return on capital
Debt/Equity0.01Low debt
💎

Valuation & Profitability

P/E Ratio
15.33x
Industry Average P/E
31.77x
Dividend Yield
1.57%
Market Cap
₹506.05 (Cr)
Sales Growth 5Y
4.99%
Profit Growth 5Y
16.18%
EPS Growth 5Y
17.09%
OPM 5Y Avg
22.75%
📉

Price Returns

1 Month
-9.92%
3 Months
-0.52%
6 Months
-11.43%
1 Year
-6.48%
52W Low
₹944
Current
₹955
52W High
₹1410
2% of 52-week range — Near lows
🔬

Technical Indicators

52RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹1035
▼ Price below SMA 50 — Bearish
SMA 200
₹1145
▼ Long-term downtrend
Volume Signal
172% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Jenburkt Pharmaceuticals Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowPharmaceuticals StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.